Glycoprotein G is a major target for the humoral immune response against herpes simplex virus (HSV) and a prototype antigen for type-specific serodiagnosis discriminating HSV-1 and HSV-2 infections. The mature part of HSV-2 glycoprotein G-2 (gG-2) contains a unique stretch suspected to mediate type specificity, and in addition a region homologous to HSV-1 glycoprotein G-1 (gG-1). Antigenic determinants of the mature gG-2 were mapped by testing the reactivity of mouse antigG-2 monoclonal antibodies (MAbs) and purified human anti-gG-2 antibodies with synthetic peptides coupled to cellulose membranes. The anti-gG-2 MAbs bound to four epitopes localized in a narrow cluster within a gG-2 segment delimited by amino acids (aa) 552 and 611. This cluster was located between the predicted O-glycan-rich region and the
Introduction
Herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) infections elicit mostly a type-common antibody response with extensive cross-reactivity. In contrast to all other HSV glycoproteins in which both type-common and type-specific determinants have been defined, glycoproteins G-1 (gG-1) and G-2 (gG-2) are unique in that only a type-specific antibody response has been described. These proteins have therefore successfully been exploited for HSV serotyping (Ashley et al., 1988 ; Ho et al., 1992 Ho et al., , 1993 Lee et al., 1985 Lee et al., , 1986 Svennerholm et al., 1984) . The gG-2 gene consists of 2097 nucleotides (McGeoch et al., 1987) encoding a 699 aa long protein which is cleaved during processing into a secreted portion and a carboxy-terminal part containing a roughly equal number of amino acids (Su et al., 1993) . The latter, which is modified by an Author for correspondence : Jan-AH ke Liljeqvist.
Fax j46 31 604960. e-mail liljeja!clavicula.mednet.gu.se transmembrane anchor sequence. The epitopes of the human anti-gG-2 antibodies were localized within three stretches of amino acids, two of which were overlapping with those recognized by antigG-2 MAbs. One of these stretches, delimited by aa 552 and 574, showed reactivity to all human HSV-2 sera tested, but not to HSV-1 sera or to purified anti-gG-1 antibodies. Neither the anti-gG-2 MAbs nor the purified human anti-gG-2 antibodies were cross-reactive to gG-1 peptides or HSV-1 antigen, although most of the epitopes were localized within the part of gG-2 which was homologous to gG-1. The findings concerning HSV-2 type-specific human antibody response to a defined stretch within gG-2 may be of importance for the further development of type-discriminating serodiagnosis.
extensive O-glycosylation (Balachandran & Hutt-Fletcher, 1985 ; Marsden et al., 1984 ; Olofsson et al., 1986 ) and exposed on virus-infected cell membranes (Su & Courtney, 1988) , represents the mature gG-2. The mature gG-2 contains both a unique part and one which is homologous to gG-1. Whether the unique part contains the type-specific gG-2 epitopes is unknown, since only scarce information is available on the precise localization of the B-cell epitopes (Balachandran & Hutt-Fletcher, 1985 ; Levi et al., 1996 ; Su et al., 1993) .
For definition of epitopes of single antibodies, X-ray crystallography of antibody-antigen complexes is regarded as the only means of direct observation of contacting residues (for a review see Davies & Cohen, 1996) . The pepscan technique utilizing synthetic peptides (Geysen et al., 1987) has been successfully exploited for the recognition of linear stretches of amino acids within epitopes. This method has been further developed by employing peptides coupled to continuous cellulose (Frank, 1992 ; Kramer et al., 1994) or immobilon AV membranes (Gao & Esnouf, 1996) for mapping of linear J.-A H . Liljeqvist and others J.-A H . Liljeqvist and others (Kramer et al., 1993 (Kramer et al., , 1994 as well as discontinuous epitopes (Gao & Esnouf, 1996 ; Korth et al., 1997 ; Reineke et al., 1995) .
In this study, we have produced anti-gG-2 monoclonal antibodies (MAbs) as well as purified human anti-gG-2 antibodies for mapping of the B-cell epitopes in the mature gG-2. Since HSV-2-positive sera and anti-gG-2 MAbs are reactive with denatured mature gG-2 antigen in immunoblot (Ashley et al., 1988 (Ashley et al., , 1992 , a pepscan technique based on peptides coupled to cellulose membranes was selected for mapping purposes.
Methods
Cells and virus strains. African green monkey kidney (GMK-AH1) and human epidermoid (HEp-2) cells were cultured in Eagle's MEM supplemented with 2 % calf serum. Baby hamster kidney (BHK-21) cells were propagated in Glasgow MEM with 8 % calf serum, 1 % -glutamine and 8 % tryptose phosphate broth. Mouse embryonal cells (3T12-3) were cultured in Iscove's medium supplemented with 8 % FCS, 1n5% -glutamine and 1 % sodium pyruvate. The HSV-2 strains used were strain 333 and one local wild-type strain designated B4327UR (Nilheden et al., 1983) . HSV-2 HG52 strain mutant JH2609, which lacks a functional gG-2 (Harland & Brown, 1988) , was kindly provided by M. Brown (Glasgow University, UK). Virus stocks were prepared in GMK-AH1 cells.
Antigen preparation and MAb production. The mature gG-2 was purified from 3T12-3-infected cells (strain B4327UR) by Helix pomatia (HPA) lectin affinity chromatography as described earlier (Olofsson et al., 1981) , and used for immunization. MAbs were produced according to standard hybridoma techniques (Fazekas de St Groth & Scheidegger, 1980) using F\O cells, and positive hybridomas were cloned by limiting dilution. For large-scale production of MAbs the hybridoma cells were cultured in dialysis tubing as described earlier (Sjo$ gren-Jansson & Jeansson, 1985) . Subclass specificity was determined by radial immunodiffusion (The Binding Site Ltd).
Serum samples from HSV-infected patients. Sera were collected from five HSV-2 and 10 HSV-1 isolation positive patients. The virus isolates were defined as HSV-1 or HSV-2 by using an immunoassay in GMK-AH1-infected cells and MAbs (Nilheden et al., 1983) . In addition, three sera were also included which contained HSV-2 antibodies to HPA lectin-purified gG-2 from patients without clinical isolates.
Purification of human HSV sera. HPA lectin-purified gG-2 and a truncated form of gG-1 prepared in CHO cells (kindly provided by SmithKline Beecham) were coupled to epoxy-activated Sepharose 6B (Pharmacia Biotech) at pH 12 according to the manufacturer's instructions. Human sera were clarified by centrifugation for 10 min and the supernatant was diluted 1 : 5 in TBS supplemented with 0n5 % Tween 80. Before use, the affinity column was equilibrated with the same dilution buffer and the serum sample was applied and circulated through the column for 1 h at room temperature. After washing, the antibodies were eluted with 0n1 M glycine-HCl pH 2n8 and neutralized with 1 M Tris-HCl pH 8.
Enzyme immunoassays of anti-gG-2 MAbs. The mature gG-2 was purified from BHK-21-infected cells (strain B4327UR) by HPA lectin affinity chromatography. The antigen (0n1 mg\ml) was diluted 1 : 6000 in carbonate buffer (pH 9n6) and used for coating of Maxisorp microtitre plates (Nunc) overnight at 4 mC. Non-infected GMK-AH1 and a typecommon sodium deoxycholate-solubilized membrane preparation of HSV-1 served as controls. Each MAb was used at a concentration of 50 µg\ml. Peroxidase-conjugated F(abh) # goat antimouse IgG at a 1 : 1000 dilution (Jackson) was used as conjugate, with Ophenylenediamine as substrate. End-point titres were expressed as the reciprocal of the dilution giving an absorbance value greater than cut-off after subtraction of reactivity to non-infected cell antigens. For definition of cut-off, reactivity was defined for each of the anti-gG-2 MAbs to three unrelated control antigens. The absorbance value to the antigen giving the highest mean value (Toxoplasma gondii) plus 3 SD was selected as the cut-off. The MAbs were also tested for their reactivity with monolayers of GMK-AH1 cells in 96-well plates infected with HSV-2 strain 333 or B4327UR and HSV-1 strain KOS 321. When cytopathic effect was well advanced, the cells were fixed with 0n25 % glutaraldehyde as described earlier (Trybala et al., 1994) and the enzyme immunoassay was performed as described above. Enzyme immunoassays of human sera and purified human anti-gG-2 antibodies. The purified human anti-gG-2 antibodies and the corresponding sera were also tested for reactivity to HPA lectinpurified gG-2 and HSV-1 antigen coated in microtitre plates (Nunc). The gG-2 monospecificity of the purified human antibodies was also tested by an indirect ELISA using the gG-1 antigen, and by an immunoassay carried out on the surface of GMK-AH1 cells that had been infected with HSV-2 mutant JH2609. The cut-off for HSV-2-positive sera was defined as follows for the different antigens : for the HPA lectin-purified gG-2 antigen, as the mean absorbance value of HSV-1-specific sera plus 0n2 OD units ; and for the HSV-1 antigen and the HSV-2 mutant JH2609 antigen, as the mean absorbance values for HSV-negative sera plus 0n2 OD units. The mean absorbance value for the purified human anti-gG-2 antibodies to the gG-1 antigen plus 3 SD was used as the cut-off value when these antibodies were tested for reactivity to the different HSV antigens. Since sera from rabbits immunized with Epstein-Barr virus (EBV) or cytomegalovirus (CMV) have been shown to cross-react with gG-2 (Balachandran et al., 1987) , the purified human anti-gG-2 antibodies were also tested in ELISA for reactivity against CMV and varicella zoster virus (VZV) and in indirect immunofluorescence against EBV.
Immunoblot of anti-gG-2 MAbs and purified human antigG-2 antibodies. Antigen for immunoblot was prepared for the antigG-2 MAbs by infecting HEp-2 cells with HSV-2 strain 333 and B4327UR. HSV-1 antigen was produced by using strain KOS 321. For the purified human gG-2 antibodies and HSV-2 sera, only the HSV-2 strain 333 was used. After SDS-PAGE under reducing conditions (Bergstro$ m et al., 1990 ) the proteins were electrotransferred to nitrocellulose membranes. The antibodies were incubated overnight with respective antigens, and peroxidase-labelled rabbit anti-mouse and antihuman IgG (DAKO) were used as conjugate and 4-chloro-1-naphthol as substrate.
Pepscan analysis of anti-gG-2 MAbs. For screening purposes a panel of overlapping peptides spanning the entire gG-2 sequence (13-mers, overlapping by 11 aa) was prepared on a continuous cellulose membrane support (Jerini Bio Tools) according to the standard spot synthesis protocol (Frank, 1992 ; Kramer et al., 1994) . Before use, the membranes were washed once in methanol and three times in TBS containing 0n05 % Tween 20 pH 8n0 (T-TBS) and incubated overnight with blocking buffer (Genosys Biotechnologies) diluted 1 : 10 in T-TBS with addition of 50 mg\ml of sucrose. The MAbs were diluted in blocking buffer at a concentration of 0n1 µg\ml and incubated with membranes for 3 h at room temperature. After triple washing, peroxidaseconjugated F(abh) # goat anti-mouse IgG (Jackson) was added in blocking buffer at a concentration of 0n2 µg\ml and incubated for 2 h. After washing, the membranes were developed with enhanced chemiluminescence detection solution on X-Omat S film. For a more precise localization of the epitopes, selected 15-mer peptides overlapping by 14 aa were synthesized and used as described above. -End-point titres less than 100. * Helix pomatia lectin-purified gG-2. † Sodium deoxycholate-solubilized HSV-1-infected membrane preparations. ‡ GMK-AH1 cells were infected with a HSV-2 strain HG52 derivative JH2609 which lacks gG-2 expression.
Pepscan analysis of HSV-2 sera and purified human antigG-2 antibodies. A panel of overlapping peptides spanning the gG-2 sequence from aa 201 to 699 (13-mers, overlapping by 10 aa) was prepared as described above. Each sample of the purified human anti-gG-2 antibodies was diluted 1 : 40 in blocking buffer and incubated separately with the membrane for 3 h at room temperature. Peroxidase-conjugated F(abh) # goat anti-human IgG (Jackson) was used as conjugate at a concentration of 0n2 µg\ml. A mixture of unpurified sera obtained from the patients with clinical HSV-2 isolates (patient nos 1-5) and another mixture of four HSV-1-specific sera were tested at a 1 : 100 dilution. The membranes were regenerated according to the manufacturer's instructions using 2 % SDS and 100 mM 2-mercaptoethanol in 50 mM Tris-HCl pH 6n7, and tested with the conjugate alone to exclude residual activity.
Competitive indirect ELISA of purified human anti-gG-2 antibodies. Synthetic peptides (15-mers) comprising the predicted epitopes were synthesized using F-moc synthesis chemistry (kindly provided by M. Levy, Karolinska Institute, Stockholm, Sweden) or purchased from K. J. Ross-Petersen AS, Denmark. The peptides for each individual patient were mixed (for patient no. 2, one peptide, see Table  3 below) and incubated at different concentrations with the purified human anti-gG-2 antibodies at room temperature for 18 h. In parallel, three 15-mer peptides spanning aa 261-295 in gG-2 and a 23-mer gG-1 peptide were used as controls. The mixtures were assayed as described above in an indirect ELISA with gG-2 as target antigen.
Results
The anti-gG-2 MAbs were tested in immunoblots and in enzyme immunoassays on cell monolayers using either HSV-2 strain 333 or B4327UR as infecting virus. Since the reactivity was essentially identical the results are shown for strain 333. 
Production and reactivity of anti-gG-2 MAbs and purified human anti-gG-2 antibodies
Following immunization of mice and fusion of spleen cells, five hybridoma lines secreting gG-2-specific MAbs were identified. All MAbs were of the IgG " isotype (data not shown). The possibility that the MAbs were identical was excluded by isoelectric focusing and agarose gel electrophoresis assays (data not shown). All MAbs bound to HPA lectin-purified gG-2 in an indirect ELISA assay and to monolayers of HSV-2-infected cells with varying end-point titres (Table 1) . In control experiments, MAbs were tested simultaneously for their reactivity with HSV-1 membrane antigen in ELISA and with cells infected with HSV-1 strain KOS 321. Both tests produced negative results (Table 1) .
Human anti-gG-2 antibodies were purified by gG-2 affinity chromatography from sera collected from eight HSV-2-infected individuals. The reactivity of these antibodies, as well as of the original sera, to different HSV antigens is summarized in Table 2 . The gG-2 specificity of purified human gG-2 antibodies was further confirmed by their lack of reactivity with solubilized HSV-1 antigen, with cells infected with an HSV-2 gG-2-negative mutant (Table 2 ) and with the recombinant truncated gG-1 antigen (data not shown). The reactivity of the purified gG-2 antibodies with CMV and VZV antigen in indirect ELISA was similar to the BSA control, and no reactivity was seen with EBV-infected cells in indirect immunofluorescence at a 1 : 10 dilution (data not shown).
All anti-gG-2 MAbs (shown for MAb O1.C5.B2) and all the purified human anti-gG-2 antibodies were reactive to gG-2 in immunoblot ( Fig. 1 ) and recognized proteins with apparent molecular masses of 74 and 112-118 kDa. The lower band represents the high-mannose intermediate which is further processed by O-glycosylation to yield the mature gG-2 shown as the upper band (Balachandran & Hutt-Fletcher, 1985 ; Marsden et al., 1984 ; Olofsson et al., 1986) . In addition, other distinct bands are visible which may represent different processed or degraded forms of gG-2. None of the anti-gG-2 MAbs was reactive with antigens prepared from non-infected or from HSV-1-infected cells (data not shown). In conclusion, these findings indicate that the purified human anti-gG-2 antibodies, as well as the anti-gG-2 MAbs, exclusively bind to the gG-2 protein with no cross-reactivity to HSV-1 or gG-1 antigen.
Mapping of gG-2 epitopes with MAbs
For screening purposes gG-2 peptides (13-mers, overlapping by 11 aa spanning the entire gG-2 sequence) coupled to a continuous cellulose membrane were selected to map the epitopes. With the antibody concentrations used, the background MAb reactivity with other peptides as well as the reactivity of the conjugate alone was low. For a more precise localization of the epitopes, a set of 15-mer peptides overlapping by 14 aa were synthesized by the same technique. Each Fig. 3. (a) The overall reactivity (black spots) of purified human anti-gG-2 antibodies from eight HSV-2-infected patients with peptides spanning the gG-2 sequence from aa 201 to 699 (13-mers, overlapping by 10 aa) coupled to a cellulose membrane. The antibodies from each patient were incubated with the membrane followed by addition of peroxidaseconjugated secondary antibodies. The binding was visualized with chemilumiscence. The respective numbers adjacent to the reactive spots refer to the gG-2 amino acid sequences listed in Table 3 . Additional peptide reactivity of unpurified HSV-2 sera is marked with open circles of which sera from patients nos 1 and 3 were reactive to the single spot in row 3 and all sera except for that from patient no. 8 were reactive to the spots in rows 5 and 6. (b) Purified human anti-gG-2 antibodies (patient nos 1-5) showed no reactivity with gG-1 synthetic peptides spanning the entire gG-1 sequence (13-mers, overlapping by 11 aa) coupled to a cellulose membrane. membrane contained 17-21 spots (peptides), and positive spots with their corresponding sequences are listed in Fig. 2 . Note that the anti-gG-2 MAbs O1.C5.B2 and O2.E10.A3 recognized similar epitopes (Fig. 2) although the intensity of reactivity to the different peptides within the epitope was different. As a control, the gG-2-specific MAbs were tested for reactivity to gG-1 peptides spanning the entire gG-1 sequence (13-mers, overlapping by 11 aa) coupled to a cellulose membrane as described above, and were all found to be unreactive (data not shown). In addition, four MAbs reactive to other HSV glycoproteins were also tested for binding to the gG-2 membrane and were all found to be negative (data not shown).
Mapping of gG-2 epitopes with purified human antigG-2 antibodies
Purified human anti-gG-2 antibodies from eight patients were incubated with gG-2 peptides (13-mers, overlapping by 10 aa ; in total 163 peptides) coupled to a continuous cellulose membrane. Two identical membranes were used with regeneration of the membrane after each sample tested. The overall reactivity of the purified human anti-gG-2 antibodies with the gG-2 peptides is shown in Fig. 3 (a) (the different films were superimposed onto each other). The reactivity for each patient to the respective gG-2 peptide sequences is listed in Table 3 . Reactivity of purified human anti-gG-1 and gG-2 antibodies as well as for HSV-1 sera to gG-2 synthetic peptides using a pepscan technique
The reactivity to different gG-2 peptides is marked vertically ($). The reactive amino acid sequences are depicted in bold italic and the immunodominant stretch with reactivity for all anti-gG-2 antibodies is underlined. A weak reactivity for mixed HSV-1 sera against one peptide is also marked (#). The numbers in the left column refer to the reactive spots in Fig. 3(a) . The numbering of the gG-2 amino acids is from McGeoch et al. (1987) .
RGTARTPPTDPKT ARTPPTDPKTHPH PPTDPKTHPHGPA DPKTHPHGPADAP THPHGPADAPPGS HGPADAPPGSPAP ADAPPGSPAPPPP P P G S PA P P P P E H R SPAPPPPEHRGGP PPPPEHRGGPEEF PEHRGGPEEFEGA RGGPEEFEGAGDG PEEFEGAGDGEPP FEGAGDGEPPEDD AGDGEPPEDDDSA GEPPEDDDSATGL PEDDDSATGLAFR DDSATGLAFRTPN ATGLAFRTPNPNK L A F R T P N P N K P P P R T P N P N K P P PA R P N P N K P P PA R P G P I K P P PA R P G P I R P T PA R P G P I R P T L P P P G P I R P T L P P G I L IRPTLPPGILGPL TLPPGILGPLAPN Table 3 , and the reactive peptides are depicted in bold italics. Note that the gG-2 peptides showing reactivity to all samples are the most prominent in respect of intensity and size. The background signal, as well as the reactivity of the conjugate alone, was low. None of the purified human anti-gG-2 antibodies was reactive with the gG-1 peptides coupled to a cellulose membrane (Fig. 3 b) . Furthermore, purified gG-1 antibodies from 10 patients with a verified HSV-1 infection (isolate proven) showed no cross-reactivity when incubated with the gG-2 pepscan membrane (Table 3 ). In addition, four HSV-1 sera were mixed and tested for reactivity to the same gG-2 membrane. Except for a weak signal to one peptide (Table 3) , no reactivity was seen. The possibility that unpurified HSV-2 sera contained antibodies which were not bound to the HPA lectin-purified gG-2 column was tested separately. In general, the positive signal was weaker with a somewhat higher background (data not shown). However, two additional stretches of amino acids were clearly recognized. These spots are marked with open circles in Fig. 3 (a) . Sera from patients nos 1 and 3 were reactive to aa $%& ALTEDTSSDSPTS $&( (Fig. 3 a,  row 3) ; and all sera except for that from patient no. 8 were reactive to aa &!"
PPATAPGPSA &"! , (Fig. 3 a, rows 5 and 6 ).
Competitive indirect ELISA of purified human anti-gG-2 antibodies
Synthetic peptides comprising the predicted epitopes were incubated at different concentrations with the anti-gG-2 antibodies, and the inhibition was evaluated in an indirect ELISA with HPA lectin-purified gG-2 as target antigen. The stretch of gG-2 amino acid residues reactive to all purified human anti-gG-2 antibodies (deduced from the pepscan data, BCCA Fig. 4 . The inhibition of binding of purified human anti-gG-2 antibodies from eight patients to HPA lectin-purified gG-2 with specific gG-2 peptides comprising the predicted epitope(s). The specific as well as control peptides were used at a concentration of 0n1 µg/ml and incubated overnight at room temperature with the anti-gG-2 antibodies. The reactivity was assayed with HPA lectin-purified gG-2 antigen by indirect ELISA.
see Table 3 ) was shortened by 5 aa at the carboxy-terminal end, since no reactivity was seen to the neighbouring peptide overlapping by 10 aa. Thus, a 23-mer synthetic peptide comprising the gG-2 aa &&# PPPPEHRGGPEEFEGAGDGEP-PE &(% was used as a specific peptide with the corresponding gG-1 peptide sequence PMPSIGLEEEEEEEGAGDGEHLE as a control. The other gG-2-specific epitopes were contained within three different 15-mer peptides. The inhibition of reactivity ( 50 % of the OD values) of the purified human anti-gG-2 antibodies mixed with the specific peptides, used at a concentration of 0n1 µg\ml, in comparison with unrelated control peptides, is shown in Fig. 4 .
The gG-1 control peptide did not significantly inhibit the reactivity of the purified human anti-gG-2 antibodies from any of the patients with the exception of patient no. 1. Therefore the reactivity of the purified anti-gG-2 antibodies from this patient to this region was fine mapped by the pepscan technique employing 15-mer peptides overlapping by 14 aa. The mapped epitope contained the gG-2 amino acid sequence
EFEGAGD &'* which is almost identical to the corresponding gG-1 sequence (underlined are amino acid residues shared with gG-1). However, no cross-reactivity was seen for these antigG-2 antibodies when the above gG-1 peptide (23-mer) was coupled to a cellulose membrane, suggesting that a short peptide in solution may be more flexible and cross-reactive. As a control peptide for the competitive ELISA evaluation of the purified gG-2 antibodies from this patient, one of the other 15-mer gG-2 peptides not containing the predicted epitopes was used.
In conclusion, the anti-gG-2 MAbs identified three stretches of amino acids representing four epitopes delimited by aa 552 and 611. The purified human anti-gG-2 antibodies also bound to three regions in which two stretches of gG-2 amino acids were similar to the anti-gG-2 MAbs epitopes (Fig .   Fig. 5 . Schematic presentation of the carboxy-terminal portions of HSV glycoprotein G. The proposed cleavage site (/) and the O-glycan-rich region are indicated in gG-2, and the transmembrane regions (TMR) are indicated for both proteins. The homologous regions of the gG-1 and gG-2 glycoproteins are illustrated with filled boxes ; open boxes represent the mapped gG-2 epitopes that were recognized by five out of eight purified human anti-gG-2 antibody samples, respectively. The hatched box in the middle represents the immunodominant stretch of gG-2 amino acids to which all HSV-2 sera were reactive. The four mapped epitopes for the anti-gG-2 MAbs are marked with vertical lines. The numbering of the gG-2 amino acids is from McGeoch et al. (1987) . 5). Note that the epitopes for all of the anti-gG-2 MAbs, as well as the epitopes with reactivity for all of the purified human anti-gG-2 antibodies, were localized within the part of gG-2 homologous with gG-1. No cross-reactivity to HSV-1 antigen was seen using the pepscan technique for the anti-gG-2 MAbs or for the purified human anti-gG-2 antibodies. In addition, purified human anti-gG-1 antibodies or HSV-1 sera showed no cross-reactivity to the gG-2 epitope regions, indicating that the immune response to gG-1 and gG-2 is type-specific.
Discussion
Herpesvirus glycoproteins, exposed on the envelopes of the virus particles as well as on the surface of infected cells, are potent inducers of a B-cell immune response and are widely used as serological antigens. In HSV infection, antibodies to gG are readily detected, and can effectively discriminate between HSV-1 and HSV-2 (for a review see Bergstro$ m & Trybala, 1996) . The nature of this type-specific sero-reactivity is hitherto unknown, but the unique regions existing in gG-1 and gG-2 (McGeoch et al., 1985 (McGeoch et al., , 1987 could be expected to harbour HSV-1-and HSV-2-type-specific epitopes, respectively. In the present study this hypothesis was tested by epitope mapping a panel of HSV type-specific MAbs reactive with the mature part of gG-2 and also of purified human antigG-2 antibodies by using a pepscan technique based on peptides coupled to cellulose membranes.
Although the mature gG-2 contains a large unique stretch of amino acid residues absent from gG-1, the reactivity of the anti-gG-2 MAbs and the purified human anti-gG-2 antibodies shown by the pepscan analysis revealed that most of their epitopes were clustered within the region homologous to gG-1. A parallel observation has previously been made for another HSV-1 envelope protein, glycoprotein C (gC), where epitopes defined by type-specific MAbs were exclusively localized to a J.-A H . Liljeqvist and others J.-A H . Liljeqvist and others region with an extensive amino acid homology with HSV-2 gC (Bergstro$ m & Trybala, 1996 ; Wu et al., 1990) . Within this homologous region of gG-2 a stretch of amino acid residues was found with which all purified human anti-gG-2 antibodies (but none of the purified anti-gG-1 antibodies), as well as three anti-gG-2 MAbs, were reactive. With the reservation that relatively few human sera were tested, this stretch is suggested to represent an immunodominant region of the mature gG-2.
Several overlapping epitopes were probably present, as judged by the different patterns within this immunodominant region of reactivity of the human polyclonal gG-2 sera in the pepscan analysis. These differences could also be explained by the existence of strain variability of the sequence encoding the suggested immunodominant region among clinical HSV-2 isolates. However, one of the anti-gG-2 MAbs (O1.C5.B2) reactive to this region has been used for routine sub-typing of clinical HSV isolates at the Department of Virology, Go$ teborg, for several years. Of the last 1000 HSV-2 strains tested, the anti-gG-2 MAb was reactive to 99 % isolates (unpublished observation) indicating that this region is exposed and well conserved.
Glycoprotein G-2 has been reported to be cleaved during processing into an amino-terminal portion which is secreted into the extracellular medium (Su et al., 1987 (Su et al., , 1993 Su & Courtney, 1988) (Balachandran & Hutt-Fletcher, 1985 ; Marsden et al., 1984 ; Olofsson et al., 1986) . The reactivity of all the anti-gG-2 MAbs, and the predominant reactivity of purified human antigG-2 antibodies to the region shared with HSV-1 rather than the unique part of the mature gG-2, could therefore be dependent on the predicted heavy O-glycosylation of the unique part (Hansen et al., 1995) . As shown earlier for tumour cells, shortening of O-glycan chains which occurred in the mucin-like proteins leads to exposure of the normally hidden epitopes (Brockhausen et al., 1995) . The O-glycans may therefore act as a protective shield against the B-cell immune response for the underlying amino acid residues.
If such shielding is the case for mature gG-2, the HPA lectin-purified antigen with its selection for O-glycan-rich regions, which was the antigen used in immunization for the production of MAbs and for purification of human gG-2 antibodies, may have limited the B-cell immunoreactive regions of gG-2 which were detected. However, the reactivity of a commercially available gG-2 reactive MAb (ABI) (Levi et al., 1996) was also localized in the homologous region within a peptide containing the predicted epitope for the anti-gG-2 MAb O3.G11.H7. Furthermore, the additional reactivity of unpurified human sera as compared to purified gG-2 antibodies was limited to two peptides in which threonines 356 and 504 within these peptides are predicted to be O-glycosylated. Despite the existence of reactivity of human sera to some epitopes in the unique part of the mature gG-2, we suggest that the predominant B-cell immune response is directed against the homologous region. Taken together, these observations indicate that predictions of the localization of type-specific epitopes on HSV glycoproteins based on genetic sequence comparisons alone are of limited value.
The use of synthetic peptides for epitope mapping is well known to be biased towards detection of short linear stretches of amino acids (Laver et al., 1990) . Therefore, we cannot exclude that the antigenic regions described for the anti-gG-2 MAbs and the purified human gG-2 antibodies are separate parts of a discontinuous epitope or epitopes, or that other discontinuous gG-2 epitopes were excluded with the pepscan technique used. However, the significant inhibition by a mixture of specific peptides of the binding of purified human anti-gG-2 antibodies to mature gG-2 suggests that at least the major part of the reactive amino acid residues were included in the predicted epitopes of gG-2 described in the present study.
For serodiagnostic purposes, it might be of relevance that all the tested purified human anti-gG-2 antibodies were reactive with an immunodominant region of the mature gG-2 protein comprising aa 552-574. One epitope was mapped within this region to an amino acid stretch in which six out of seven residues were shared with the corresponding gG-1 sequence. Despite this extensive homology, no cross-reactivity was seen for any of the anti-gG-2 antibodies with native or denatured HSV-1 antigen, or with gG-1 antigen or homologous gG-1 peptides. In addition, since gG-1 antibodies and HSV-1 sera were unreactive with this immunodominant gG-2 region, it may be a promising candidate for use as antigen in the development of peptide-based HSV-2-specific serology.
